We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Economics influences therapy decisions in chronic myeloid leukaemia: should it?
- Authors
Jiang, Qian; Larson, Richard A.; Gale, Robert Peter
- Abstract
The question whether economic considerations should influence therapy decisions in persons with chronic myeloid leukaemia (CML) is complex touching on many metrics other than medicine including the perceptions, attitudes, and motivations of physicians, patients, their families, and payors', allocation of health care resources, and others. We discuss metrics whereby physicians, patients, and payors make CML therapy choices in settings where cost and availability are or are not considerations. We conclude that economic considerations strongly influence therapy decisions in CML. Whether this should be so and what impact it has on outcomes is also considered. Absent definitive data proving which therapy strategy is best allowing economic considerations to operate may not be as unreasonable or unethical as it appears. In some settings, it may be the best approach. However, because TKIs markedly prolong survival and may even cure some persons with CML, TKI therapy should be available to everyone with CML.
- Subjects
CHRONIC myeloid leukemia; PHYSICIANS
- Publication
Journal of Cancer Research & Clinical Oncology, 2021, Vol 147, Issue 12, p3693
- ISSN
0171-5216
- Publication type
Article
- DOI
10.1007/s00432-021-03607-5